# Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

> **NCT01753830** · NA · TERMINATED · sponsor: **Galderma R&D** · enrollment: 75 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** Durolane
- **DEVICE:** PBS

## Key facts

- **NCT ID:** NCT01753830
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** Study terminated early due to decision by sponsor
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753830, "Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01753830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*